Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Neurodegener Dis. 2012 Jul 10;11(4):165–181. doi: 10.1159/000337230

Figure 5. CD45 immunoreactivity was prominent in rTg4510 mouse brain and it did not alter following acute injections of oligomers.

Figure 5

Micrographs represent CD45 immunoreactivity in the frontal cortex (CX) and hippocampus (HPC) of rTg4510 mice following Sc Aβ (A, B, n=5) or OLIGO injections (C, D, n=5). Staining density was analysed as percent of stained area for each region and graphed as ratio of ipsilateral to the contralateral side (E, F). The scale bar represents 50μm.